Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls
Sign Up to like & getrecommendations! Published in 2021 at "Obesity Surgery"
DOI: 10.1007/s11695-020-04969-4
Abstract: The objective of this research was to characterize the impact of Roux-en-Y gastric bypass (RYGB) on the pharmacokinetic properties of the pro-drug lisdexamfetamine and its active metabolite, d-amphetamine. A case-control design was used where patients… read more here.
Keywords: gastric bypass; plasma concentration; nonsurgical controls; lisdexamfetamine ... See more keywords
Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: Exploration of a binge-like eating model
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacology Biochemistry and Behavior"
DOI: 10.1016/j.pbb.2020.172851
Abstract: Diets high in sugar or fat are associated with multiple health conditions, including binge eating disorder (BED). BED affects approximately 2% of the US adult population, and occurs more frequently in females. It is important… read more here.
Keywords: chocolate; food intake; group; lisdexamfetamine ... See more keywords
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2112950
Abstract: ABSTRACT Introduction Lisdexamfetamine dimesylate (LDX) is a prodrug approved for attention deficit/hyperactivity disorder and for moderate-to-severe binge eating disorder in adults in some countries. Area covered We aimed to specify the abuse potential of LDX… read more here.
Keywords: expert opinion; potential abuse; lisdexamfetamine; review ... See more keywords